Trials / Withdrawn
WithdrawnNCT03494803
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
Clinical Trials on Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC and T Cells
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- HKGepitherapeutics · Industry
- Sex
- Male
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
Prostate cancer is a leading cause of mortality and morbidity. The purpose of this study is to develop and test non-invasive biomarkers based on methylation changes in PBMC, T-cells and circulated tumor DNA in prostate cancer patients.
Conditions
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2018-04-11
- Last updated
- 2023-12-22
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT03494803. Inclusion in this directory is not an endorsement.